STOCK TITAN

Mannatech Reports First Quarter End 2022 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Mannatech, Incorporated (NASDAQ: MTEX) reported first quarter 2022 financial results with net sales of $32.4 million, a decline of 15.5% from $38.3 million in Q1 2021. On a constant dollar basis, net sales decreased by 11.5%. Supply chain issues led to deferred revenue of $0.9 million in Asia Pacific, affecting sales. Operating income fell to less than $0.1 million compared to $2.8 million in Q1 2021, while net income was $0.1 million, or $0.06 per diluted share. The number of fulfilled orders decreased by 6%, and recruitment of associates dropped by 5.1%.

Positive
  • Selling and administrative expenses decreased by $0.2 million to $6.9 million.
  • Other operating costs decreased by $0.2 million to $4.9 million.
Negative
  • Net sales declined by 15.5%, primarily due to supply chain constraints.
  • Operating income fell to less than $0.1 million from $2.8 million in Q1 2021.
  • Recruitment of new associates decreased by 5.1%.

FLOWER MOUND, Texas--(BUSINESS WIRE)-- Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2022.

First Quarter End Results

First quarter net sales for 2022 were $32.4 million, a decrease of $5.9 million, or 15.5%, as compared to $38.3 million in the first quarter of 2021. Our net sales declined 11.5% on a constant dollar basis (see Non-GAAP Measures, below) and foreign exchange decreased GAAP net sales by $1.5 million, mostly due to the decline of the Korean Won and Japanese Yen. During the quarter, supply chain constraints impacted our sales. As a result, we had to postpone planned promotions as we were sourcing and shipping product. We deferred revenue of orders shipped but not received by customers, in particular in our Asia Pacific market. In Hong Kong, we have deferred $0.9 million revenue for orders shipped but not received by customers. The number of product fulfilled orders decreased by 6.0% to 189,700 for the three months ended March 31, 2022, as compared to 201,729 during the same period in 2021.

First quarter operating income for 2022 was less than $0.1 million as compared to $2.8 million for the first quarter of 2021.

Net income was $0.1 million, or $0.06 per diluted share, for the first quarter of 2022, as compared to net income of $2.2 million, or $1.04 per diluted share, for the first quarter of 2021.

For the three months ended March 31, 2022, overall selling and administrative expenses decreased by $0.2 million to $6.9 million, as compared to $7.1 million for the same period in 2021. The decrease in selling and administrative expenses consisted of a $0.1 million decrease in marketing costs and a $0.1 million decrease in contract labor costs.

For the three months ended March 31, 2022, other operating costs decreased by $0.2 million to $4.9 million, as compared to $5.1 million for the same period in 2021. The decrease in operating costs was primarily due to a $0.2 million decrease in legal and consulting fees.

The approximate number of new and continuing independent associate and preferred customer positions held by individuals in Mannatech’s network and associated with purchases of products as of March 31, 2022 and 2021 were approximately 157,000 and 187,000, respectively. Recruitment of new independent associates and preferred customers decreased by 5.1% to 18,542 in the first quarter of 2022 as compared to 19,538 in the first quarter of 2021.

Non-GAAP Measures

In addition to results presented in accordance with GAAP, this press release and related tables include certain non-GAAP financial measures, including a presentation of constant dollar measures. We disclose operating results that have been adjusted to exclude the impact of changes due to the translation of foreign currencies into U.S. dollars, including changes in: Net Sales, Gross Profit, and Income from Operations. We believe that these non-GAAP financial measures provide useful information to investors because they are an indicator of the strength and performance of ongoing business operations. The constant currency figures are financial measures used by management to provide investors an additional perspective on trends. Although we believe the non-GAAP financial measures enhance investors’ understanding of our business and performance, these non-GAAP financial measures should not be considered an exclusive alternative to accompanying GAAP financial measures. Please see the accompanying table entitled "Non-GAAP Financial Measures" for a reconciliation of these non-GAAP financial measures.

Safe Harbor statement

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” “hope,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” “potential,” and “continues” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, the impact of COVID-19 on Mannatech’s business, the availability and effectiveness of vaccines on a widespread basis, the impact of any mutations of the COVID-19 virus, the current conflict between Russia and Ukraine, which could adversely affect our business in certain regions, the impact of inflation, disruptions in the supply chain, Mannatech's inability to attract and retain associates and preferred customers, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Individuals interested in Mannatech's products or in exploring its business opportunity can learn more at Mannatech.com

MANNATECH, INCORPORATED AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except share information)

 
 

March 31, 2022

 

December 31,

ASSETS

 

(unaudited)

 

2021

Cash and cash equivalents

 

$

23,359

 

 

$

24,185

 

Restricted cash

 

 

944

 

 

 

944

 

Accounts receivable, net of allowance of $991 and $987 in 2022 and 2021, respectively

 

 

91

 

 

 

90

 

Income tax receivable

 

 

385

 

 

 

342

 

Inventories, net

 

 

12,591

 

 

 

12,020

 

Prepaid expenses and other current assets

 

 

3,798

 

 

 

2,888

 

Deferred commissions

 

 

3,103

 

 

 

2,369

 

Total current assets

 

 

44,271

 

 

 

42,838

 

Property and equipment, net

 

 

2,591

 

 

 

2,882

 

Construction in progress

 

 

1,507

 

 

 

1,357

 

Long-term restricted cash

 

 

503

 

 

 

503

 

Other assets

 

 

9,528

 

 

 

9,220

 

Deferred tax assets, net

 

 

2,740

 

 

 

2,825

 

Total assets

 

$

61,140

 

 

$

59,625

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

Current portion of finance leases

 

$

60

 

 

$

68

 

Accounts payable

 

 

5,122

 

 

 

3,969

 

Accrued expenses

 

 

8,407

 

 

 

9,224

 

Commissions and incentives payable

 

 

9,629

 

 

 

9,611

 

Taxes payable

 

 

1,756

 

 

 

2,154

 

Current notes payable

 

 

608

 

 

 

205

 

Deferred revenue

 

 

6,617

 

 

 

4,867

 

Total current liabilities

 

 

32,199

 

 

 

30,098

 

Finance leases, excluding current portion

 

 

69

 

 

 

66

 

Deferred tax liabilities

 

 

 

 

 

 

Long-term notes payable

 

 

 

 

 

 

Other long-term liabilities

 

 

5,142

 

 

 

5,049

 

Total liabilities

 

 

37,410

 

 

 

35,213

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding

 

 

 

 

 

 

Common stock, $0.0001 par value, 99,000,000 shares authorized, 2,742,857 shares issued and 1,949,716 shares outstanding as of March 31, 2022 and 2,742,857 shares issued and 1,940,687 shares outstanding as of December 31, 2021

 

 

 

 

 

 

Additional paid-in capital

 

 

33,359

 

 

 

33,277

 

Retained earnings

 

 

7,452

 

 

 

7,708

 

Accumulated other comprehensive income

 

 

1,669

 

 

 

2,342

 

Treasury stock, at average cost, 793,141 shares as of March 31, 2022 and 802,170 shares as of December 31, 2021

 

 

(18,750

)

 

 

(18,915

)

Total shareholders’ equity

 

 

23,730

 

 

 

24,412

 

Total liabilities and shareholders’ equity

 

$

61,140

 

 

$

59,625

 

MANNATECH, INCORPORATED AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share information)

 

Three Months Ended

 

 

March 31,

 

 

2022

 

2021

Net sales

 

$

32,384

 

 

$

38,319

 

Cost of sales

 

 

7,091

 

 

 

7,222

 

Gross profit

 

 

25,293

 

 

 

31,097

 

Operating expenses:

 

 

 

 

Commissions and incentives

 

 

13,108

 

 

 

15,598

 

Selling and administrative expenses

 

 

6,909

 

 

 

7,111

 

Depreciation and amortization expense

 

 

332

 

 

 

510

 

Other operating costs

 

 

4,909

 

 

 

5,089

 

Total operating expenses

 

 

25,258

 

 

 

28,308

 

Income from operations

 

 

35

 

 

 

2,789

 

Interest income, net

 

 

15

 

 

 

22

 

Other income (expense), net

 

 

85

 

 

 

(282

)

Income before income taxes

 

 

135

 

 

 

2,529

 

Income tax (provision)

 

 

(1

)

 

 

(335

)

Net income

 

$

134

 

 

$

2,194

 

Earnings per common share:

 

 

 

 

Basic

 

$

0.07

 

 

$

1.06

 

Diluted

 

$

0.06

 

 

$

1.04

 

Weighted-average common shares outstanding:

 

 

 

 

Basic

 

 

1,947

 

 

 

2,071

 

Diluted

 

 

2,074

 

 

 

2,116

 

Non-GAAP Financial Measures (Sales, Gross Profit and Income from Operations in Constant Dollars)

To supplement our financial results presented in accordance with generally accepted accounting principles in the United States (“GAAP”), we disclose operating results that have been adjusted to exclude the impact of changes due to the translation of foreign currencies into U.S. dollars, including changes in: Net Sales, Gross Profit, and Income from Operations. We refer to these adjusted financial measures as constant dollar items, which are non-GAAP financial measures. We believe these measures provide investors an additional perspective on trends. To exclude the impact of changes due to the translation of foreign currencies into U.S. dollars, we calculate current year results and prior year results at a constant exchange rate, which is the prior year’s rate. Currency impact is determined as the difference between actual growth rates and constant currency growth rates.

The table below reconciles first quarter 2022 constant dollar net sales, gross profit and income from operations to our GAAP net sales, gross profit and income from operations.

March 31,

 

Three-month period ended (in millions, except percentages)

 

March 31, 2022

 

2021

 

Constant $ Change

 

 

GAAP

 

Non-GAAP

 

GAAP

 

 

 

 

Measure:

Measure:

Measure:

Total $

Constant $

Total $

Dollar

Percent

Net Sales

 

$

32.4

 

$

33.9

 

$

38.3

 

$

(4.4

)

 

(11.5

)%

Product

 

 

30.8

 

 

32.2

 

 

35.9

 

 

(3.7

)

 

(10.3

)%

Pack and associate fees

 

 

1.3

 

 

1.4

 

 

2.2

 

 

(0.8

)

 

(36.4

)%

Other

 

 

0.3

 

 

0.3

 

 

0.2

 

 

0.1

 

 

50.0

%

Gross profit

 

 

25.3

 

 

26.4

 

 

31.1

 

 

(4.7

)

 

(15.1

)%

Income from operations

 

 

 

 

0.2

 

 

2.8

 

 

(2.6

)

 

(92.9

)%

 

Donna Giordano

Manager, Executive Office Administration

972-471-6512

ir@mannatech.com

www.mannatech.com

Source: Mannatech, Incorporated

FAQ

What were Mannatech's net sales for Q1 2022?

Mannatech's net sales for Q1 2022 were $32.4 million, down 15.5% from Q1 2021.

How did the supply chain impact Mannatech in Q1 2022?

Supply chain constraints led to a deferral of $0.9 million in revenue from the Asia Pacific market.

What was the operating income for Mannatech in Q1 2022?

Mannatech reported operating income of less than $0.1 million in Q1 2022.

How many independent associates did Mannatech recruit in Q1 2022?

Mannatech recruited 18,542 independent associates in Q1 2022, a decrease of 5.1% from the prior year.

Mannatech Inc.

NASDAQ:MTEX

MTEX Rankings

MTEX Latest News

MTEX Stock Data

21.49M
1.14M
39.43%
20.41%
0.11%
Food Distribution
Medicinal Chemicals & Botanical Products
Link
United States of America
FLOWER MOUND